Literature DB >> 11044398

FGF signalling controls the timing of Pax6 activation in the neural tube.

N Bertrand1, F Médevielle, F Pituello.   

Abstract

We have recently demonstrated that Pax6 activation occurs in phase with somitogenesis in the spinal cord. Here we show that the presomitic mesoderm exerts an inhibitory activity on Pax6 expression. This repressive effect is mediated by the FGF signalling pathway. The presomitic mesoderm displays a decreasing caudorostral gradient of FGF8, and grafting FGF8-soaked beads at the level of the neural tube abolishes Pax6 activation. Conversely, when FGF signalling is disrupted, Pax6 is prematurely activated in the neural plate. We propose that the progression of Pax6 activation in the neural tube is controlled by the caudal regression of the anterior limit of FGF activity. Hence, as part of its posteriorising activity, FGF8 downregulation acts as a switch from early (posterior) to a later (anterior) state of neural epithelial development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044398     DOI: 10.1242/dev.127.22.4837

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  18 in total

1.  FGF-dependent Notch signaling maintains the spinal cord stem zone.

Authors:  Jun Akai; Pam A Halley; Kate G Storey
Journal:  Genes Dev       Date:  2005-11-14       Impact factor: 11.361

2.  Requirement of mesodermal retinoic acid generated by Raldh2 for posterior neural transformation.

Authors:  Natalia Molotkova; Andrei Molotkov; I Ovidiu Sirbu; Gregg Duester
Journal:  Mech Dev       Date:  2005-02       Impact factor: 1.882

3.  Control of the segmentation process by graded MAPK/ERK activation in the chick embryo.

Authors:  Marie-Claire Delfini; Julien Dubrulle; Pascale Malapert; Jérome Chal; Olivier Pourquié
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

4.  Noggin and basic FGF were implicated in forebrain fate and caudal fate, respectively, of the neural tube-like structures emerging in mouse ES cell culture.

Authors:  Shunmei Chiba; Manae S Kurokawa; Hideshi Yoshikawa; Ritsuko Ikeda; Mitsuhiro Takeno; Mamoru Tadokoro; Hiroaki Sekino; Takuo Hashimoto; Noboru Suzuki
Journal:  Exp Brain Res       Date:  2005-02-10       Impact factor: 1.972

5.  FGF signaling enhances a sonic hedgehog negative feedback loop at the initiation of spinal cord ventral patterning.

Authors:  Aixa V Morales; Sergio Espeso-Gil; Inmaculada Ocaña; Francisco Nieto-Lopez; Elena Calleja; Paola Bovolenta; Mark Lewandoski; Ruth Diez Del Corral
Journal:  Dev Neurobiol       Date:  2015-12-08       Impact factor: 3.964

Review 6.  Regulatory pathways linking progenitor patterning, cell fates and neurogenesis in the ventral neural tube.

Authors:  James Briscoe; Bennett G Novitch
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

7.  FGF and retinoic acid activity gradients control the timing of neural crest cell emigration in the trunk.

Authors:  Patricia L Martínez-Morales; Ruth Diez del Corral; Isabel Olivera-Martínez; Alejandra C Quiroga; Raman M Das; Julio A Barbas; Kate G Storey; Aixa V Morales
Journal:  J Cell Biol       Date:  2011-08-01       Impact factor: 10.539

8.  Retinoic acid-dependent signaling pathways and lineage events in the developing mouse spinal cord.

Authors:  Marie Paschaki; Song-Chang Lin; Rebecca Lee Yean Wong; Richard H Finnell; Pascal Dollé; Karen Niederreither
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

9.  Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm.

Authors:  Ethan S Lippmann; Clay E Williams; David A Ruhl; Maria C Estevez-Silva; Edwin R Chapman; Joshua J Coon; Randolph S Ashton
Journal:  Stem Cell Reports       Date:  2015-04-02       Impact factor: 7.765

10.  Antagonizing retinoic acid and FGF/MAPK pathways control posterior body patterning in the invertebrate chordate Ciona intestinalis.

Authors:  Andrea Pasini; Raoul Manenti; Ute Rothbächer; Patrick Lemaire
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.